AMAN

10.0900.10%
SC

Sandeep Chidambar Kulkarni

Co-Founder, CEO & Director

Dr. Sandeep Chidambar Kulkarni, MD., serves as Director at OHB Pediatrics Ltd since June 08, 2026. He is Chairman of the Board of Amanat Acquisition Corp from May 18, 2026. He has been Chief Executive Officer at Zura Bio Limited since January 21, 2026 and also serves as Co-Founder. He was Chief Operating Officer of Immunovant, Inc. He serves as Co-Founder and CEO at Tourmaline Bio, Inc and served as Director until October 28, 2025. From July to October 2018, he served as Vice President, Special Projects, at Roivant Sciences, Inc. He served as Independent Director at Zura Bio Limited since March 31, 2022 until 2024 and is its Director since 2024. He was the Chief Executive Officer and co-founder of Tourmaline Bio, LLC, since September 2021 until October 28, 2025. Prior to this, Dr. Kulkarni was a Managing Director at KVP Capital from August 2020 to June 2022. Prior to KVP, Dr. Kulkarni served in multiple roles at Roivant Sciences from July 2018 to June 2020, including as the Chief Operating Officer of lmmunovant, Inc, Vice President Special Projects and Ombudsman to the Investment Committee. From September 2017 to February 2018, Dr. Kulkarni was a Senior Investment Analyst at Consonance Capital and an Investment Analyst on the Life Sciences team at QVT Financial LP from April 2013 to August 2017. From August 2009 to May 2012, Dr. Kulkarni was a Consultant, then Project Leader at the Boston Consulting Group, Inc., where he focused on the biopharma sector. Dr. Kulkarni earned a B.A. in Economics from Harvard College and an M.D. from the University of California, San Francisco.

Positions